V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
ISSN 1068-1760
I
N
Vol. 39 No.4 • 6-7/2022
T
E
World’s First Rapid Oral Cancer Test
R
N
A
T
I
O
DAILY CLINICAL LAB NEWS
®
N
Machine Learning Drastically Reduces Workload of Diagnostic Cell Counting
U
ntil now there hasn’t been a perfect way to identify pre-malignant lesions that are likely to develop into mouth cancer. Without knowing definitively whether a lesion is cancerous, patients with pre-malignancy must be reviewed regularly over a long
M
achine learning methods are increasingly spreading into the area of blood cell counting, until recently dominated by expensive and often less accurate traditional cell analyzers. However, due to the enormous amount of manual annotation work required,
training the machine learning model has so far proven highly labor-intensive. Now, researchers have developed an innovative training method that automates much of this activity. Researchers at Beihang University (Beijing, China; ev.buaa.edu.cn)
Cont’d on page 8
Cont’d on page 18
Study Points to Crucial Gaps in Children’s Clinical Testing
I
S
I
R E A D E R
S E R V I C E
Point-of-Care Analyzer Performs Complete Blood Count in 5 Minutes
W
orld’s first lab-quality portable plug-and-play Complete Blood Count (CBC) analyzer allows real-time blood testing to be performed by anyone, anywhere. By providing critical health data on the spot, the analyzer enables rapid diagnostic results and data-driven disease management decisions. Cont’d on page 10
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
esearchers have developed a rapid test for viruses that can deliver results as accurate as lab tests within 30 minutes. The technology can be applied to viruses that cause respiratory syncytial virus, influenza and COVID-19. A new study by researchers from the University of Texas at Dallas (Dallas, TX, USA; www. utdallas.edu) demonstrated the
he advent of next-generation sequencing (NGS) technology has enabled the diagnostic workup of patients suspected of having primary immunodeficiency disorders, which will have significant implications for not only their diagnosis and prognosis but also provide opportunities for targeted therapeutic management and family planning. Cont’d on page 14
®
Identify LinkXpress codes of 1 interest as you read magazine
R
Next-Gen Sequencing for Immunodeficiencies
T
LINKXPRESS COM
Multi-Virus Test Offers Results in 30 Minutes
T
See article on page 6
V
L
Cont’d on page 10
A
breakthrough study by a research team affiliated with the AACC reveals significant inconsistencies in pediatric reference intervals that are critical to clinical testing, and calls for the development of reliable standards in the field.
A
Two Industry Giants Combine to Form QuidelOrtho
Q
uidelOrtho Corporation (San Diego, CA, USA; www. quidelortho.com) announced completion of the merger uniting Quidel Corporation (San Diego, CA, USA) and Ortho Clinical Diagnostics (Raritan, NJ, USA), forging QuidelOrtho as a leading in vitro diagnostics concern.
Quidel acquired Ortho in December 2021, in a USD 6 billion transaction that aims to unite technologies and platforms to offer expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening and, point-of-care diagnostic offerings. Cont’d on page 22
INSIDE
COVID-19 Update. . . . . 4 Clinical News. . . . . . 6-28 IFCC News. . . . . . . . . . 29 Product News . . . . . 6-28 Industry News . . . . . . . 33 Events Calendar . . . . . 34
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<